The global market for Single Gene Genetic Disease Screening Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Single gene genetic disease screening service is a medical service that identifies individuals who carry genetic mutations associated with specific genetic diseases caused by a single gene. The screening process typically involves a blood test or saliva sample analysis to determine whether a person has a genetic mutation that can cause a particular single-gene disorder, such as cystic fibrosis, sickle cell anemia, or Huntington"s disease.
The purpose of this screening service is to identify individuals who may be carriers of these genetic mutations and who could pass them on to their children. It allows couples to make informed decisions about their reproductive options, such as undergoing pre-implantation genetic diagnosis (PGD), prenatal testing, or considering adoption. This screening service can also be used for individuals who have a family history of a specific genetic disease to determine whether they are at risk of developing the disease themselves or passing it on to their children.
North American market for Single Gene Genetic Disease Screening Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Single Gene Genetic Disease Screening Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Single Gene Genetic Disease Screening Services in Assisted Reproduction is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Single Gene Genetic Disease Screening Services include Yikon, BGI, DiagCor Bioscience, CapitalBio Technology, ANNOROAD, Berry Genomics, Chengdu 23Mofang Biotechnology, WeGene, Peking Jabrehoo Med Tech, AIERKANG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Single Gene Genetic Disease Screening Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Gene Genetic Disease Screening Services.
The Single Gene Genetic Disease Screening Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Single Gene Genetic Disease Screening Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Gene Genetic Disease Screening Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Yikon
BGI
DiagCor Bioscience
CapitalBio Technology
ANNOROAD
Berry Genomics
Chengdu 23Mofang Biotechnology
WeGene
Peking Jabrehoo Med Tech
AIERKANG
YUNKANG
BOKE bioscience
Guangzhou Darui Biotechnology
Shanghai Find Biotechnology
USCI
Segment by Type
Pre-Pregnancy
Early Pregnancy
Others
Segment by Application
Assisted Reproduction
Scientific Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Gene Genetic Disease Screening Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Single Gene Genetic Disease Screening Services 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pre-Pregnancy
1.2.3 Early Pregnancy
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Single Gene Genetic Disease Screening Services 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Assisted Reproduction
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Gene Genetic Disease Screening Services 麻豆原创 Perspective (2020-2031)
2.2 Global Single Gene Genetic Disease Screening Services Growth Trends by Region
2.2.1 Global Single Gene Genetic Disease Screening Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Single Gene Genetic Disease Screening Services Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Single Gene Genetic Disease Screening Services Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Single Gene Genetic Disease Screening Services 麻豆原创 Dynamics
2.3.1 Single Gene Genetic Disease Screening Services Industry Trends
2.3.2 Single Gene Genetic Disease Screening Services 麻豆原创 Drivers
2.3.3 Single Gene Genetic Disease Screening Services 麻豆原创 Challenges
2.3.4 Single Gene Genetic Disease Screening Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Gene Genetic Disease Screening Services Players by Revenue
3.1.1 Global Top Single Gene Genetic Disease Screening Services Players by Revenue (2020-2025)
3.1.2 Global Single Gene Genetic Disease Screening Services Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Single Gene Genetic Disease Screening Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Single Gene Genetic Disease Screening Services Revenue
3.4 Global Single Gene Genetic Disease Screening Services 麻豆原创 Concentration Ratio
3.4.1 Global Single Gene Genetic Disease Screening Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Gene Genetic Disease Screening Services Revenue in 2024
3.5 Global Key Players of Single Gene Genetic Disease Screening Services Head office and Area Served
3.6 Global Key Players of Single Gene Genetic Disease Screening Services, Product and Application
3.7 Global Key Players of Single Gene Genetic Disease Screening Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Gene Genetic Disease Screening Services Breakdown Data by Type
4.1 Global Single Gene Genetic Disease Screening Services Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Single Gene Genetic Disease Screening Services Forecasted 麻豆原创 Size by Type (2026-2031)
5 Single Gene Genetic Disease Screening Services Breakdown Data by Application
5.1 Global Single Gene Genetic Disease Screening Services Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Single Gene Genetic Disease Screening Services Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Single Gene Genetic Disease Screening Services 麻豆原创 Size (2020-2031)
6.2 North America Single Gene Genetic Disease Screening Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2020-2025)
6.4 North America Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Gene Genetic Disease Screening Services 麻豆原创 Size (2020-2031)
7.2 Europe Single Gene Genetic Disease Screening Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2020-2025)
7.4 Europe Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Gene Genetic Disease Screening Services 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Single Gene Genetic Disease Screening Services 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Single Gene Genetic Disease Screening Services 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Single Gene Genetic Disease Screening Services 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Gene Genetic Disease Screening Services 麻豆原创 Size (2020-2031)
9.2 Latin America Single Gene Genetic Disease Screening Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Gene Genetic Disease Screening Services 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Single Gene Genetic Disease Screening Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Single Gene Genetic Disease Screening Services 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Yikon
11.1.1 Yikon Company Details
11.1.2 Yikon Business Overview
11.1.3 Yikon Single Gene Genetic Disease Screening Services Introduction
11.1.4 Yikon Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.1.5 Yikon Recent Development
11.2 BGI
11.2.1 BGI Company Details
11.2.2 BGI Business Overview
11.2.3 BGI Single Gene Genetic Disease Screening Services Introduction
11.2.4 BGI Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.2.5 BGI Recent Development
11.3 DiagCor Bioscience
11.3.1 DiagCor Bioscience Company Details
11.3.2 DiagCor Bioscience Business Overview
11.3.3 DiagCor Bioscience Single Gene Genetic Disease Screening Services Introduction
11.3.4 DiagCor Bioscience Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.3.5 DiagCor Bioscience Recent Development
11.4 CapitalBio Technology
11.4.1 CapitalBio Technology Company Details
11.4.2 CapitalBio Technology Business Overview
11.4.3 CapitalBio Technology Single Gene Genetic Disease Screening Services Introduction
11.4.4 CapitalBio Technology Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.4.5 CapitalBio Technology Recent Development
11.5 ANNOROAD
11.5.1 ANNOROAD Company Details
11.5.2 ANNOROAD Business Overview
11.5.3 ANNOROAD Single Gene Genetic Disease Screening Services Introduction
11.5.4 ANNOROAD Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.5.5 ANNOROAD Recent Development
11.6 Berry Genomics
11.6.1 Berry Genomics Company Details
11.6.2 Berry Genomics Business Overview
11.6.3 Berry Genomics Single Gene Genetic Disease Screening Services Introduction
11.6.4 Berry Genomics Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.6.5 Berry Genomics Recent Development
11.7 Chengdu 23Mofang Biotechnology
11.7.1 Chengdu 23Mofang Biotechnology Company Details
11.7.2 Chengdu 23Mofang Biotechnology Business Overview
11.7.3 Chengdu 23Mofang Biotechnology Single Gene Genetic Disease Screening Services Introduction
11.7.4 Chengdu 23Mofang Biotechnology Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.7.5 Chengdu 23Mofang Biotechnology Recent Development
11.8 WeGene
11.8.1 WeGene Company Details
11.8.2 WeGene Business Overview
11.8.3 WeGene Single Gene Genetic Disease Screening Services Introduction
11.8.4 WeGene Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.8.5 WeGene Recent Development
11.9 Peking Jabrehoo Med Tech
11.9.1 Peking Jabrehoo Med Tech Company Details
11.9.2 Peking Jabrehoo Med Tech Business Overview
11.9.3 Peking Jabrehoo Med Tech Single Gene Genetic Disease Screening Services Introduction
11.9.4 Peking Jabrehoo Med Tech Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.9.5 Peking Jabrehoo Med Tech Recent Development
11.10 AIERKANG
11.10.1 AIERKANG Company Details
11.10.2 AIERKANG Business Overview
11.10.3 AIERKANG Single Gene Genetic Disease Screening Services Introduction
11.10.4 AIERKANG Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.10.5 AIERKANG Recent Development
11.11 YUNKANG
11.11.1 YUNKANG Company Details
11.11.2 YUNKANG Business Overview
11.11.3 YUNKANG Single Gene Genetic Disease Screening Services Introduction
11.11.4 YUNKANG Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.11.5 YUNKANG Recent Development
11.12 BOKE bioscience
11.12.1 BOKE bioscience Company Details
11.12.2 BOKE bioscience Business Overview
11.12.3 BOKE bioscience Single Gene Genetic Disease Screening Services Introduction
11.12.4 BOKE bioscience Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.12.5 BOKE bioscience Recent Development
11.13 Guangzhou Darui Biotechnology
11.13.1 Guangzhou Darui Biotechnology Company Details
11.13.2 Guangzhou Darui Biotechnology Business Overview
11.13.3 Guangzhou Darui Biotechnology Single Gene Genetic Disease Screening Services Introduction
11.13.4 Guangzhou Darui Biotechnology Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.13.5 Guangzhou Darui Biotechnology Recent Development
11.14 Shanghai Find Biotechnology
11.14.1 Shanghai Find Biotechnology Company Details
11.14.2 Shanghai Find Biotechnology Business Overview
11.14.3 Shanghai Find Biotechnology Single Gene Genetic Disease Screening Services Introduction
11.14.4 Shanghai Find Biotechnology Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.14.5 Shanghai Find Biotechnology Recent Development
11.15 USCI
11.15.1 USCI Company Details
11.15.2 USCI Business Overview
11.15.3 USCI Single Gene Genetic Disease Screening Services Introduction
11.15.4 USCI Revenue in Single Gene Genetic Disease Screening Services Business (2020-2025)
11.15.5 USCI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Yikon
BGI
DiagCor Bioscience
CapitalBio Technology
ANNOROAD
Berry Genomics
Chengdu 23Mofang Biotechnology
WeGene
Peking Jabrehoo Med Tech
AIERKANG
YUNKANG
BOKE bioscience
Guangzhou Darui Biotechnology
Shanghai Find Biotechnology
USCI
听
听
*If Applicable.
